FDA Adverse Event Death Summary report: N

XACT CAROTID STENT SYSTEM

MDR report key: 1709317 · Received June 2, 2010

Report

Report Number
3004742046-2010-00237
Event Type
Death
Date Received
June 2, 2010
Date of Event
May 7, 2010
Report Date
May 7, 2010
Manufacturer
ABBOTT VASCULAR-VASCULAR SOLUTIONS
Product Code
NIM
PMA / PMN Number
P040038
Removal / Correction Number
NA
Adverse Event
Yes
Report Source
Manufacturer report
Reporter Location
UT, US
Reporter Occupation
PHYSICIAN

Narratives

Additional Manufacturer Narrative · 1

(B) (4). (B) (4). THE DEVICE WAS NOT RETURNED. THE LOT NUMBER WAS NOT PROVIDED. A F/U REPORT WILL BE SUBMITTED WITH ALL RELEVANT INFO.

Description of Event or Problem · 1

DEVICE ISSUE: NONE. ADVERSE EVENT: DEATH. ONSET OF ADVERSE EVENT: AFTER THE PROCEDURE. IT WAS REPORTED THAT THE PT UNDERWENT AN UNEVENTFUL STENTING PROCEDURE IN THE LEFT INTERNAL CAROTID ARTERY WITH THE XACT STENT. THE PT'S ACT WAS THERAPEUTIC DURING THE PROCEDURE AND THE EMBOSHIELD NA V6 WAS IN THE PT FOR LESS THAN 7 MINUTES. AFTER THE PROCEDURE, THE PT EXPERIENCED HYPOTENSION THAT WAS TREATED WITH DOPAMINE INFUSION. THE FOLLOWING DAY, THE PT DEVELOPED VENTRICULAR TACHYCARDIA THEN ASYSTOLE. ATTEMPTS TO RESUSCITATE THE PT WERE MADE FOR APPROXIMATELY THIRTY TO FORTY MINUTES BEFORE LIFE-SAVING MEASURES WERE WITHDRAWN. THE CAUSE OF THE PT'S DEATH WAS CARDIAC ARRHYTHMIA AND CARDIAC ARREST. THE PT HAD A HISTORY OF SEVERE AORTIC STENOSIS THAT WAS PLANNED TO BE TREATED WITH OPEN AORTIC VALVE REPLACEMENT AFTER HIS RECOVERY FROM THE CAROTID STENTING PROCEDURE. THERE WAS NO ADDITIONAL INFO PROVIDED.

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
1 XACT CAROTID STENT SYSTEM NIM ABBOTT VASCULAR-VASCULAR SOLUTIONS NA UNK

Patients

Seq Age Sex Outcome Treatment
1 95 YR Death VESSEL CLOSURE: STARCLOSE| EMBOLIC PROTECTION: EMBOSHIELD NA V6